BAP1 and renal cell carcinoma: Importantly, clarifying the biological mechanisms of resistance associated with absent BAP1 expression, an aberration increasingly linked to aggressive tumor behavior in renal cell carcinoma, may prove crucial in guiding future therapeutic approaches.